Health
Fluvoxamine may prevent serious illness in COVID-19 patients – China.org.cn
CHICAGO, Nov. 13 (Xinhua) — Researchers at Washington University School of Medicine in St. Louis have found in a preliminary study that the drug fluvoxamine seems to prevent some of the most serious complications of COVID-19 patients and make hospitalization and the need for supplemental oxygen less likely.
In an innovative twist to research during the pandemic, the study, involving 152 patients infected with SAR-CoV-2, the virus that causes COVID-19, was conducted remotely. When a symptomatic…
-
Business23 hours agoWhat I’d buy if I had to invest $20,000 in ASX 200 shares before the weekend
-
General22 hours agoFederal government funding extends cohealth GP services until July 2026
-
General6 hours agoMildura man given 28 years to pay $73,000 in unpaid fines and tolls
-
General9 hours agoAustralia’s race to rewire the country amid a global transmission boom is not unique